top of page

Presagen has merged with Qubist to become Qubigen.

Qubigen is an exciting new venture that merges Presagen’s Federated AI technology and Qubist’s virtual screening and AI drug design capability.


Qubigen’s mission is to create the largest global federated proprietary dataset and computational toolbox for AI driven drug design.





 
 

enquiries@qubigen.com

Bio21 Institute

30 Flemington Road

Parkville VIC 3052

Australia

Connect with Us

  • X
  • LinkedIn

© 2025 Qubigen. All rights reserved.

bottom of page